Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study
Saved in:
| Main Authors: | Jingyi Li, Yunsheng Liang, Wenli Feng, Liehua Deng, Hong Fang, Chao Ji, Youkun Lin, Furen Zhang, Rushan Xia, Chunlei Zhang, Shuping Guo, Mao Lin, Yanling Li, Shoumin Zhang, Xiaojing Kang, Liuqing Chen, Zhiqiang Song, Xu Yao, Chengxin Li, Xiuping Han, Guoxiang Guo, Qing Guo, Xinsuo Duan, Jie Li, Juan Su, Shanshan Li, Qing Sun, Juan Tao, Yangfeng Ding, Danqi Deng, Fuqiu Li, Haiyun Suo, Shunquan Wu, Jingbo Qiu, Hongmei Luo, Linfeng Li, Ruoyu Li, Lishao Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-08-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003593 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in the application of omalizumab in the treatment of chronic inducible urticaria
by: CHEN Ziyan, et al.
Published: (2024-12-01) -
Abstract 008: Morphomechanical Analysis of Saccular Aneurysms
by: Andres Gudino, et al.
Published: (2023-11-01) -
Omalizumab for Chinese patients with moderate-to-severe allergic asthma in real-world clinical setting: a prospective, observational study
by: Wen Wang, et al.
Published: (2023-07-01) -
Titanium vanadium nickel, TiV0.08Ni0.92
by: Huizi Liu, et al.
Published: (2025-02-01) -
Omalizumab en dermatología
by: Victoria Lucía Dávila, et al.
Published: (2019-08-01)